The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Dr. Keith Wilson on the Role of Helicobacter Pylori in Gastrointestinal Cancer

Keith Wilson, MD
Published Online: 10:03 PM, Fri January 29, 2016

Keith Wilson, MD, senior professor of Medicine (Gastroenterology, Hepatology & Nutrition), professor of Cancer Biology, Vanderbilt University Medical Center discusses the role helicobacter pylori plays in gastrointestinal cancer and what the next steps could be in better targeting this bacteria. 

Wilson said in his research, he and his team have found that the bacteria alters the way its host recognizes it and essentially disables the human body's ability to kill it. Wilson says his research has revealed a unique oxidative pathway that may be utilized to not only kill the bacteria, but help inflammation in patients with gastric cancer.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.